EW · 10-Q · 2026Q3 · Full report

Geographic Market Commentary

Edwards Lifesciences Corp · 2026-11-04 · Importance 42 · Surprise 40

For the first nine months of 2026, sales increased 11.9% in the United States, 17.0% in Europe, 4.4% in Japan, and 19.3% in Rest of World. Outside the United States, sales grew 15.8% overall. In the third quarter, Rest of World grew 20.2% and the United States grew 11.0%, while Japan increased 2.2%.

Key facts

• Foreign exchange rate fluctuations increased TAVR net sales by $32.5 million during the nine months ended September 30, 2026, primarily from a stronger Euro partly offset by a weaker Japanese Yen against the U.S. dollar. source